Demographic and Clinical Outcomes of Brazilian Patients With Stage III or IV Non–Small-Cell Lung Cancer: Real-World Evidence Study on the Basis of Deterministic Linkage Approach | Zendy

Carlos Gil Ferreira | Zendy; Márcia Datz Abadi | Zendy; Paula de Mendonça Batista | Zendy; Fernando Serra | Zendy; Rodrigo Buzzatti Peixoto | Zendy; Lucas Miyake Okumura | Zendy; Érica Cerqueira | Zendy

Open Access

Demographic and Clinical Outcomes of Brazilian Patients With Stage III or IV Non–Small-Cell Lung Cancer: Real-World Evidence Study on the Basis of Deterministic Linkage Approach

Author(s) -

Carlos Gil Ferreira,

Márcia Datz Abadi,

Paula de Mendonça Batista,

Fernando Serra,

Rodrigo Buzzatti Peixoto,

Lucas Miyake Okumura,

Érica Cerqueira

Publication year - 2021

Publication title -

jco global oncology

Language(s) - English

Resource type - Journals

ISSN - 2687-8941

DOI - 10.1200/go.21.00228

Subject(s) - medicine , lung cancer , stage (stratigraphy) , regimen , cancer , cohort , retrospective cohort study , oncology , paleontology , biology

Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer and accounts for 80%-90% of the cases. In Brazil, between 2018 and 2019, lung cancer was ranked as the second most frequent cancer among men and the fourth among women. The primary objectives were to describe the journey and survival rates of patients with advanced NSCLC treated in the Brazilian private health care system (HCS).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research